MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

1.77
Delayed Data
As of May 18
 +0.09 / +5.36%
Today’s Change
1.05
Today|||52-Week Range
5.70
-15.71%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 54.00, with a high estimate of 54.00 and a low estimate of 54.00. The median estimate represents a +2,950.85% increase from the last price of 1.77.

Analyst Recommendations

There are no recommendations available.

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.07
Sales
$0.00
Reporting Date
Aug 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.82%
 
 
 
 
 
 
Growthannually 16.59%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.